Cancer in in Eld lderly in in Denmark - Route to Diagnosis, - - PowerPoint PPT Presentation

cancer in in eld lderly in in denmark
SMART_READER_LITE
LIVE PREVIEW

Cancer in in Eld lderly in in Denmark - Route to Diagnosis, - - PowerPoint PPT Presentation

Cancer in in Eld lderly in in Denmark - Route to Diagnosis, Treatment and Prognosis Project proposal by: - Bolette Danckert (Danish Cancer Society) - Henry Jensen (Centre for Cancer Diagnosis in Primary Care, Aarhus) - Georgios


slide-1
SLIDE 1

Cancer in in Eld lderly in in Denmark

  • Route to Diagnosis, Treatment and Prognosis

Project proposal by:

  • Bolette Danckert (Danish Cancer Society)
  • Henry Jensen (Centre for Cancer Diagnosis in Primary Care, Aarhus)
  • Georgios Lyratzopoulos (UCL, London)
  • Sean McPhail (National Cancer Registration and Analysis Service in Public Health England)
  • Annette Fischer Pedersen (Department of Clinical Medicine at Aarhus University)
  • Niels Lyhne Christensen (Danish Cancer Society)
  • Alina Zounina Falborg (Centre for Cancer Diagnosis in Primary Care, Aarhus)
  • Henrik Frederiksen (AgeCare elite research centre at Odense University Hospital)
  • Henrik Møller (Danish Clinical Registries)
  • Linda Aagaard Thomsen (Danish Cancer Society)
  • Peter Vedsted (Centre for Cancer Diagnosis in Primary Care, Aarhus)
slide-2
SLIDE 2

Presentation Agenda

  • Status:
  • Velux application submitted.
  • Start Summer 2019.
  • Project presentation
  • Background
  • Research Questions
  • Data and Methods
  • Perspectives
  • ICBP
  • Routine monitoring
  • Potential Nordic projects
slide-3
SLIDE 3

Motivation

  • Increasing number of cancer incidences among the

elderly

  • Poorer survival among elderly patients
  • Little evidence on the elderly exists
  • Potential importance of comorbidities and potential

undertreatment

  • Unanswered questions:
  • Is the poor survival due to inadequate healthcare seeking

behaviour?

  • Is it related to the choices made by healthcare professionals?
  • Or could it be the result of undertreatment?
slide-4
SLIDE 4

Existing studies

  • Studies among general population
  • Routes to diagnosis
  • Standardized cancer patient pathways
  • Treatment

Patterns for the elderly population?

  • Distribution
  • Relation to prognosis
  • Depending on personal characteristics
  • Socio-economy, social network,

comorbidities

  • Depending on structural factors
  • Urbanisation degree

Route to diagnosis First Treatment Treatment starts Diagnosis

slide-5
SLIDE 5

Research Questions

RQ1 Where do elderly cancer patients present in the healthcare system prior to their cancer diagnosis? RQ2 How is the route to diagnosis associated with the prognosis of cancer in elderly cancer patients? RQ3 Which patient and structural parameters are associated with routes to diagnosis in elderly cancer patients? RQ4 Which treatment modalities are elderly cancer patients undergoing? RQ5 How is the treatment modality associated with the prognosis of elderly cancer patients? RQ6 Which patient and structural parameters are associated with the treatment of elderly cancer patients?

slide-6
SLIDE 6

Data

  • Population:

70+ at time of diagnosis

  • Time period:

2014-2017 (diagnosis year)

  • Data:

Danish Cancer Registry

(Diagnosis, date of diagnosis, tumour, node and metastasis (TNM) stage, municipality and region of residence, age and sex)

National Patient Register

(Admissions, procedures (e.g. surgery, radiotherapy, chemotherapy, imaging), CPPs, diagnosis codes, procedure codes and dates)

Civil Registration System

(Vital status, marital status and home address)

Statistics Denmark

(Income, education and social network (marital status and children), degree of urbanisation (city size))

Danish Health Service Register

(List size (number of patients) of general practices)

slide-7
SLIDE 7

Perspectives

  • Facilitate better diagnostics and more efficient

treatment

  • Research perspectives:
  • International Cancer Benchmarking Program (ICBP),

module 9

  • Routine monitoring
  • Nordic projects regarding standardized cancer patient

pathways. 21 provinces:

  • England
  • Ireland
  • Northern Ireland
  • Wales
  • Scotland
  • Denmark
  • Norway
  • Canada
  • New Zealand